Cargando…

Dosimetry, Efficacy, Safety, and Cost-Effectiveness of Proton Therapy for Non-Small Cell Lung Cancer

SIMPLE SUMMARY: Non-small cell lung cancer (NSCLC) is the most common malignancy requiring radiotherapy (RT) as an important part of its multimodality treatment, the emergence of proton therapy may further allow for a sharper dose of build-up and drop-off com-pared to photon therapy, which has poten...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Bin, Men, Yu, Wang, Junjie, Hui, Zhouguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465697/ https://www.ncbi.nlm.nih.gov/pubmed/34572772 http://dx.doi.org/10.3390/cancers13184545

Ejemplares similares

A Current Review of Dose-escalated Radiotherapy in Locally Advanced Non-small Cell Lung Cancer
por: Ma, Li, et al.
Publicado: (2019)

Combined neat model for the prognosis of postoperative stage III‐N2 non‐small cell lung cancer
por: Zhai, Yirui, et al.
Publicado: (2020)

Tumor Mutation Load: A Novel Independent Prognostic Factor in Stage IIIA-N2 Non-Small-Cell Lung Cancer
por: Kang, Jingjing, et al.
Publicado: (2019)

Real world practice of postoperative radiotherapy for patients with completely resected pIIIA-N2 non-small cell lung cancer: a national survey of radiation oncologists in China
por: Zhou, Shujie, et al.
Publicado: (2023)

Preclinical Dosimetry for Small Animal Radiation Research in Proton Therapy: A Feasibility Study
por: Biltekin, Fatih, et al.
Publicado: (2023)

Endostar (rh‐endostatin) improves efficacy of concurrent chemoradiotherapy for locally advanced non‐small cell lung cancer: A systematic review and meta‐analysis
por: Yuan, Meng, et al.
Publicado: (2021)

Non-small cell lung cancer therapy: safety and efficacy in the elderly
por: Glotzer, Owen S, et al.
Publicado: (2013)

The Impact of Cardiac Radiation Dosimetry on Survival After Radiation Therapy for Non-Small Cell Lung Cancer
por: Vivekanandan, S., et al.
Publicado: (2017)

Characterization of a Low-Cost Plastic Fiber Array Detector for Proton Beam Dosimetry
por: Ozkan Loch, Cigdem, et al.
Publicado: (2020)

Higher Lung and Heart Doses Decrease Early and Long-Term Survival, Respectively, in Patients With Non-Small Cell Lung Cancer Undergoing Postoperative Radiation
por: Ma, Zeliang, et al.
Publicado: (2023)

Safety and Efficacy of Pemetrexed in Maintenance Therapy of Non-Small Cell Lung Cancer
por: Velez, Michel, et al.
Publicado: (2012)

Risk of cardiac‐related mortality in stage IIIA‐N2 non‐small cell lung cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database
por: Sun, Xin, et al.
Publicado: (2021)

Preclinical dosimetry in proton minibeam radiation therapy: Robustness analysis and guidelines
por: Ortiz, Ramon, et al.
Publicado: (2022)

The role of postoperative radiotherapy (PORT) in combined small cell lung cancer (C-SCLC)
por: Men, Yu, et al.
Publicado: (2017)

Medium-thickness-dependent proton dosimetry for radiobiological experiments
por: Shahmohammadi Beni, Mehrdad, et al.
Publicado: (2019)

A magic cube for proton/ion dosimetry
por: Brusasco, C, et al.
Publicado: (1995)

Combined proton–photon therapy for non‐small cell lung cancer
por: Amstutz, Florian, et al.
Publicado: (2022)

Postoperative radiotherapy is effective in improving survival of patients with stage pIII-N2 non-small-cell lung Cancer after pneumonectomy
por: Wang, Wenhui, et al.
Publicado: (2019)

Efficacy and safety of S-1 maintenance therapy in advanced non-small-cell lung cancer patients
por: Cheng, Xiao-Wei, et al.
Publicado: (2020)

Safety and efficacy of 10-fraction hypofractionated radiation therapy for non-small cell lung cancer
por: Yoo, Ye Jin, et al.
Publicado: (2021)

Further understanding of an uncommon disease of combined small cell lung cancer: clinical features and prognostic factors of 114 cases
por: Men, Yu, et al.
Publicado: (2016)

Scanning Beam Proton Therapy versus Photon IMRT for Stage III Lung Cancer: Comparison of Dosimetry, Toxicity, and Outcomes
por: Zou, Zhenwei, et al.
Publicado: (2020)

Postoperative radiotherapy improves survival of patients with ypN2 non‐small cell lung cancer after neoadjuvant chemotherapy followed by surgery – A propensity score matching study of the Surveillance, Epidemiology, and End Results database
por: Bao, Yongxing, et al.
Publicado: (2021)

Enhanced prediction of postoperative radiotherapy‐induced esophagitis in non‐small cell lung cancer: Dosiomic model development in a real‐world cohort and validation in the PORT‐C randomized controlled trial
por: Ma, Zeliang, et al.
Publicado: (2023)

The Efficacy and Safety of Afatinib in Non-Small Cell Lung Cancer Patients with Brain Metastasis: A Meta-Analysis
por: Jin, Hui, et al.
Publicado: (2023)

Dosimetry of medical proton beams at the JINR phasotron in Dubna
por: Kovar, I, et al.
Publicado: (1993)

Megarad dosimetry techniques used at the CERN Proton Synchrotron
por: Madsen, JHB, et al.
Publicado: (1968)

A new silicon tracker for proton imaging and dosimetry
por: Taylor, J.T., et al.
Publicado: (2016)

Proton beam therapy in non-small cell lung cancer: state of the art
por: Harada, Hideyuki, et al.
Publicado: (2017)

Proton stereotactic body radiation therapy for non-small cell lung cancer
por: Diwanji, Tejan, et al.
Publicado: (2020)

Safety and Efficacy of Vinorelbine in the Treatment of Non-Small Cell Lung Cancer
por: Faller, Bryan A., et al.
Publicado: (2011)

Efficacy and safety of icotinib as first-line therapy in patients with advanced non-small-cell lung cancer
por: Shen, Yan-Wei, et al.
Publicado: (2016)

Safety and Efficacy of Tianfoshen Oral Liquid in Non-Small Cell Lung Cancer Patients as an Adjuvant Therapy
por: Zhao, Lei, et al.
Publicado: (2019)

Bayesian network meta-analysis of efficacy and safety of neoadjuvant therapy for non-small-cell lung cancer
por: Ren, Yijiu, et al.
Publicado: (2020)

Effect of Systemic Corticosteroid Therapy on the Efficacy and Safety of Nivolumab in the Treatment of Non-Small-Cell Lung Cancer
por: Umehara, Kengo, et al.
Publicado: (2021)

International Conference on Radiation Dosimetry and Safety
por: Collective
Publicado: (1997)

The efficacy and safety of thalidomide-based therapy in patients with advanced non-small cell lung cancer: a meta-analysis
por: Liu, Ying, et al.
Publicado: (2014)

Novel Gd(3+)-doped silica-based optical fiber material for dosimetry in proton therapy
por: Hoehr, C., et al.
Publicado: (2019)

Benefit of dosimetry distribution for patients with multiple brain metastases from non-small cell lung cancer by a Cyberknife stereotactic radiosurgery (SRS) system
por: Yu, Xuyao, et al.
Publicado: (2020)

Trends and Outcomes of Proton Radiation Therapy Use for Non–Small Cell Lung Cancer
por: Moreno, Amy C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0sav65seh4hrsb2s8emjoajgsl